HishamMohamedAbdel-AzimMD
Pediatric Hematology & Oncology • Los Angeles, CAAssistant Professor, Pediatrics, USC School of Medicine
Are you Dr. Abdel-Azim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Ms# 62
Los Angeles, CA 90027Phone+1 323-669-4559Fax+1 323-660-1904
Summary
- Dr. Hisham Abdel-Azim, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California and Maine. He is affiliated with City of Hope Comprehensive Cancer Center and is an Assistant Professor at USC School of Medicine.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Westchester Medical CenterResidency, Pediatrics, 2000 - 2002
Cairo University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2002 - 2026
ME State Medical License 2007 - 2020- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Start of enrollment: 2008 Aug 01
- Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01
- The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL Start of enrollment: 2018 Aug 29
Publications & Presentations
PubMed
- 1 citationsEffect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.Christopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, Hisham Abdel-Azim, Alice Bertaina
Blood Advances. 2024-12-10 - Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.Huynh Cao, Jeffrey Xiao, David J Baylink, Vinh Nguyen, Nathan Shim
Biomedicines. 2024-10-03 - Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia.Yi Xu, David J Baylink, Jeffrey Xiao, Lily Tran, Vinh Nguyen
International Journal of Molecular Sciences. 2024-08-05
Press Mentions
- Study: Emerging Method of Stem Cell Transplantation Improves Outcomes in Children with Blood CancersJuly 14th, 2022
Obese Children with Leukemia Fared Worse in Study - US NewsOctober 27th, 2014- Loma Linda University Health’s Cell Therapy Division Receives AccreditationMarch 22nd, 2024
Professional Memberships
- Member
